| Followers | 9 |
| Posts | 3235 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Tuesday, September 09, 2025 4:24:29 PM
" there is no doubt that when the trial began PFS was the desired path to approval"
NO, clown, it wasn't the "desired path", it was the primary endpoint, AND IT FAILED!
Also, pseudoprogression is temporary, if and when it happens, obviously it didn't with DCVax because in the end - PFS was found to be worse than the placebo group! PFS- 6.2 months for DCVax vs 7.8 months for placebo! Stop lying and making sh*t up.
The trial failed and the CEO has been robbing shareholders for the last 7 years with an enormous salary and massive dilution of the stock. So there... It's likely going to a penny per share IMO... Good Luck
Gary
NO, clown, it wasn't the "desired path", it was the primary endpoint, AND IT FAILED!
Also, pseudoprogression is temporary, if and when it happens, obviously it didn't with DCVax because in the end - PFS was found to be worse than the placebo group! PFS- 6.2 months for DCVax vs 7.8 months for placebo! Stop lying and making sh*t up.
The trial failed and the CEO has been robbing shareholders for the last 7 years with an enormous salary and massive dilution of the stock. So there... It's likely going to a penny per share IMO... Good Luck
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
